Phase II trial of sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer (SCLC): Final results. This is an ASCO Meeting Abstract from the 2012 ...
Peritoneal dialysis patients with MCV of 96 fl or more had a 29% greater risk for early death compared with a reference group. SAN DIEGO—Peritoneal dialysis (PD) patients with macrocytosis have a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback